Compounds > coformycin
Page last updated: 2024-08-22

coformycin and Erythroderma, Sezary

coformycin has been researched along with Erythroderma, Sezary in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coleman, MS; Hutton, JJ; Koller, CA; Mitchell, BS; Siaw, MF1
Blanc, CM; Cataldo, F; Derossi, G; Ho, AD; Kuse, R; Lauria, F; McVie, G; Stryckmans, P; Thaler, J; Willemze, R1
Brozovic, M; Catovsky, D; Dearden, CE; Ganeshaguru, K; Hoffbrand, AV; Linch, DC; Matutes, E; Mills, M; Traub, N; Williams, HJ1
Dietz, G; Ganeshaguru, K; Ho, AD; Hoffbrand, AV; Hunstein, W; Knauf, WU; Trede, I1
Ho, AD; Kuse, R; Lauria, F; Mandelli, F; Stryckmans, P; Thaler, J; Willemze, R; Zittoun, R1
Ho, AD; Stryckmans, P; Zittoun, R1

Trials

1 trial(s) available for coformycin and Erythroderma, Sezary

ArticleYear
Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Bone marrow transplantation, 1989, Volume: 4 Suppl 1

    Topics: Adenosine; Adenosine Deaminase Inhibitors; Antineoplastic Agents; Coformycin; DNA, Neoplasm; Drug Evaluation; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Multicenter Studies as Topic; Neoplasm Proteins; Pentostatin; Ribonucleosides; Sezary Syndrome

1989

Other Studies

5 other study(ies) available for coformycin and Erythroderma, Sezary

ArticleYear
ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Proceedings of the National Academy of Sciences of the United States of America, 1980, Volume: 77, Issue:10

    Topics: Adenosine; Adenosine Deaminase Inhibitors; Adenosine Triphosphate; Aged; Coformycin; Deoxyadenine Nucleotides; Deoxyadenosines; Erythrocytes; Humans; Nucleoside Deaminases; Pentostatin; Ribonucleosides; Sezary Syndrome

1980
Membrane phenotype and response to deoxycoformycin in mature T cell malignancies.
    British medical journal (Clinical research ed.), 1987, Oct-10, Volume: 295, Issue:6603

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Membrane; Coformycin; Cyclophosphamide; Deltaretrovirus Infections; Doxorubicin; Female; Follow-Up Studies; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Pentostatin; Phenotype; Prednisone; Prognosis; Ribonucleosides; Sezary Syndrome; T-Lymphocytes; Vincristine

1987
Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo.
    Blood, 1988, Volume: 72, Issue:6

    Topics: Adenosine Deaminase Inhibitors; Adenosylhomocysteinase; Coformycin; DNA, Neoplasm; Drug Evaluation; Humans; Hydrolases; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Neoplasm Proteins; Neoplastic Cells, Circulating; Nucleotides; Pentostatin; Ribonucleosides; Sezary Syndrome

1988
Deoxycoformycin in therapy of refractory lymphoid neoplasms.
    Onkologie, 1988, Volume: 11, Issue:1

    Topics: Antineoplastic Agents; B-Lymphocytes; Coformycin; Drug Evaluation; Humans; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphoid; Lymphoma; Pentostatin; Ribonucleosides; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes

1988
Response to deoxycoformycin in mature T cell malignancies.
    British medical journal (Clinical research ed.), 1987, Dec-05, Volume: 295, Issue:6611

    Topics: Antineoplastic Agents; Coformycin; Drug Evaluation; Humans; Leukemia, Lymphoid; Pentostatin; Ribonucleosides; Sezary Syndrome

1987